# Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC

> **NCT03572829** · PHASE2 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 44 (actual)

## Conditions studied

- Vomiting
- Nausea Post Chemotherapy
- Head Neck Cancer

## Interventions

- **DRUG:** Aprepitant

## Key facts

- **NCT ID:** NCT03572829
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2020-01-09
- **Final completion:** 2020-07-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2020-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03572829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03572829, "Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03572829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*